DrugPatentWatch Database Preview

Metuchen Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for METUCHEN PHARMS, and when can generic versions of METUCHEN PHARMS drugs launch?

METUCHEN PHARMS has one approved drug.

There are two US patents protecting METUCHEN PHARMS drugs.

There are fifty-three patent family members on METUCHEN PHARMS drugs in twenty-six countries and eleven supplementary protection certificates in eleven countries.

Summary for Metuchen Pharms

International Patents:	53
US Patents:	2
Tradenames:	1
Ingredients:	1
NDAs:	1

Drugs and US Patents for Metuchen Pharms

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Metuchen Pharms	STENDRA	avanafil	TABLET;ORAL	202276-003	Apr 27, 2012		RX	Yes	Yes	7,501,409		Y
Metuchen Pharms	STENDRA	avanafil	TABLET;ORAL	202276-001	Apr 27, 2012		RX	Yes	No	7,501,409		Y
Metuchen Pharms	STENDRA	avanafil	TABLET;ORAL	202276-002	Apr 27, 2012		RX	Yes	No	6,656,935		Y	Y
Metuchen Pharms	STENDRA	avanafil	TABLET;ORAL	202276-003	Apr 27, 2012		RX	Yes	Yes	6,656,935		Y	Y
Metuchen Pharms	STENDRA	avanafil	TABLET;ORAL	202276-001	Apr 27, 2012		RX	Yes	No	6,656,935		Y	Y
Metuchen Pharms	STENDRA	avanafil	TABLET;ORAL	202276-002	Apr 27, 2012		RX	Yes	No	7,501,409		Y

Paragraph IV (Patent) Challenges for METUCHEN PHARMS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Tablets	50 mg, 100 mg and 200 mg		2016-04-27

International Patents for Metuchen Pharms Drugs

Country	Patent Number	Estimated Expiration
Japan	4588973
Taiwan	I258471
Australia	2001284444
Australia	7311800
South Korea	100610131
Mexico	PA03001958

Supplementary Protection Certificates for Metuchen Pharms Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1219609	1390047-7	Sweden		PRODUCT NAME: AVANAFIL; REG. NO/DATE: EU/1/13/841 20130621
1219609	92249	Luxembourg		PRODUCT NAME: AVANAFIL
1219609	122013000096	Germany		PRODUCT NAME: AVANAFIL UND SEINE PHARMAZEUTISCH ANNEHMBAREN SALZE; REGISTRATION NO/DATE: EU/1/13/841 20130621
1219609	13C0050	France		PRODUCT NAME: AVANAFIL; REGISTRATION NO/DATE: EU/1/13/841 20130621
1219609	476	Finland
1219609	2013/041	Ireland		PRODUCT NAME: AVANAFIL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTRATION NO/DATE: EU/1/13/841 20130613

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Metuchen Pharms